Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Exophthalmos

rosiglitazone has been researched along with Exophthalmos in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clevidence, DE; Juckett, MB; Lucarelli, MJ1
Kazim, M; Levin, F; Marcovici, E; Smith, TJ1
Goldberg, RA; Lee, S; McCann, JD; Tsirbas, A1

Other Studies

3 other study(ies) available for rosiglitazone and Exophthalmos

ArticleYear
Marrow suppression with myelodysplastic features, hypoerythropoetinemia, and lipotrophic proptosis due to rosiglitazone.
    WMJ : official publication of the State Medical Society of Wisconsin, 2009, Volume: 108, Issue:9

    Topics: Diabetes Mellitus, Type 2; Erythropoietin; Exophthalmos; Female; Humans; Hypoglycemic Agents; Lipodystrophy; Middle Aged; Myelodysplastic Syndromes; Rosiglitazone; Thiazolidinediones

2009
Rosiglitazone-induced proptosis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2005, Volume: 123, Issue:1

    Topics: Diabetes Mellitus, Type 2; Exophthalmos; Eye; Female; Humans; Hypoglycemic Agents; Middle Aged; Rosiglitazone; Thiazolidinediones; Thyroid Function Tests; Tomography, X-Ray Computed; Weight Gain

2005
Thiazolidinedione induced thyroid associated orbitopathy.
    BMC ophthalmology, 2007, Apr-26, Volume: 7

    Topics: Diplopia; Disease Progression; Drug Therapy, Combination; Exophthalmos; Female; Graves Ophthalmopathy; Humans; Hypoglycemic Agents; Magnetic Resonance Imaging; Metformin; Middle Aged; Propranolol; Propylthiouracil; Retreatment; Rosiglitazone; Thiazolidinediones

2007